DTYMK and liver cancer: When we additionally assessed the expression of this gene in PHHs and in the Hep3B, PLC/PRF5, HepG2, SK-HEP1, Huh7, and SNU398 liver cancer cell lines, we found that DTYMK was similarly overexpressed in tumor cells relative to levels in healthy PHHs (Figure 1F).